195 related articles for article (PubMed ID: 34452514)
1. The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking.
Harrison AR; David CT; Rawlinson SM; Moseley GW
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452514
[TBL] [Abstract][Full Text] [Related]
2. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.
Reid SP; Valmas C; Martinez O; Sanchez FM; Basler CF
J Virol; 2007 Dec; 81(24):13469-77. PubMed ID: 17928350
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype.
Vidal S; Sánchez-Aparicio M; Seoane R; El Motiam A; Nelson EV; Bouzaher YH; Baz-Martínez M; García-Dorival I; Gonzalo S; Vázquez E; Vidal A; Muñoz-Fontela C; García-Sastre A; Rivas C
mBio; 2021 Aug; 12(4):e0097221. PubMed ID: 34225493
[TBL] [Abstract][Full Text] [Related]
4. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.
Schwarz TM; Edwards MR; Diederichs A; Alinger JB; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974555
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Ebola Virus VP24 Protein by SUMO.
Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
[TBL] [Abstract][Full Text] [Related]
6. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
7. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1.
Xu W; Edwards MR; Borek DM; Feagins AR; Mittal A; Alinger JB; Berry KN; Yen B; Hamilton J; Brett TJ; Pappu RV; Leung DW; Basler CF; Amarasinghe GK
Cell Host Microbe; 2014 Aug; 16(2):187-200. PubMed ID: 25121748
[TBL] [Abstract][Full Text] [Related]
8. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.
Mateo M; Reid SP; Leung LW; Basler CF; Volchkov VE
J Virol; 2010 Jan; 84(2):1169-75. PubMed ID: 19889762
[TBL] [Abstract][Full Text] [Related]
9. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import.
Shabman RS; Gulcicek EE; Stone KL; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S904-10. PubMed ID: 21987768
[TBL] [Abstract][Full Text] [Related]
10. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.
Reid SP; Leung LW; Hartman AL; Martinez O; Shaw ML; Carbonnelle C; Volchkov VE; Nichol ST; Basler CF
J Virol; 2006 Jun; 80(11):5156-67. PubMed ID: 16698996
[TBL] [Abstract][Full Text] [Related]
11. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.
Zhang AP; Bornholdt ZA; Liu T; Abelson DM; Lee DE; Li S; Woods VL; Saphire EO
PLoS Pathog; 2012 Feb; 8(2):e1002550. PubMed ID: 22383882
[TBL] [Abstract][Full Text] [Related]
12. The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis.
Takamatsu Y; Kolesnikova L; Schauflinger M; Noda T; Becker S
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102881
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of STAT3 signalling by Ebola virus.
Harrison AR; Todd S; Dearnley M; David CT; Green D; Rawlinson SM; Au GG; Marsh GA; Moseley GW
PLoS Pathog; 2021 Jun; 17(6):e1009636. PubMed ID: 34166464
[TBL] [Abstract][Full Text] [Related]
14. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.
Ramanathan P; Tigabu B; Santos RI; Ilinykh PA; Kuzmina N; Vogel OA; Thakur N; Ahmed H; Wu C; Amarasinghe GK; Basler CF; Bukreyev A
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243162
[TBL] [Abstract][Full Text] [Related]
15. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
16. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
Watt A; Moukambi F; Banadyga L; Groseth A; Callison J; Herwig A; Ebihara H; Feldmann H; Hoenen T
J Virol; 2014 Sep; 88(18):10511-24. PubMed ID: 24965473
[TBL] [Abstract][Full Text] [Related]
17. Structural and mechanistic insights into nuclear transport and delivery of the critical pluripotency factor Oct4 to DNA.
Okuyama T; Yamagishi R; Shimada J; Ikeda M; Maruoka Y; Kaneko H
J Biomol Struct Dyn; 2018 Feb; 36(3):767-778. PubMed ID: 28166455
[TBL] [Abstract][Full Text] [Related]
18. Investigating Ebola virus pathogenicity using molecular dynamics.
Pappalardo M; Collu F; Macpherson J; Michaelis M; Fraternali F; Wass MN
BMC Genomics; 2017 Aug; 18(Suppl 5):566. PubMed ID: 28812539
[TBL] [Abstract][Full Text] [Related]
19. Filoviral immune evasion mechanisms.
Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
[TBL] [Abstract][Full Text] [Related]
20. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
Guito JC; Albariño CG; Chakrabarti AK; Towner JS
Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
